Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MED.DE
Strong BuyFull HouseAPPROVEMEDICLIN Aktiengesellschaft · Healthcare · Germany · $303M · Avg Vol: $69K/d
Passes eligibility hurdles. Positive, albeit modest, EPS revisions support a stable outlook for the healthcare provider.
COMPANY DESCRIPTION
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments.
FINANCIAL SUMMARY (EUR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 704.7M | 730.1M | 748.8M | 784.5M | 3.6% | 820.3M | 787.5M | 803.2M | 1.2% |
| EPS (EUR) | 0.20 | -0.23 | 0.52 | 0.54 | 39.2% | 0.62 | 0.77 | 0.80 | 21.7% |
| Shares | 47.5M | 47.5M | 47.5M | 47.5M | 0.0% | 47.5M | — | — | — |
| Debt | 502.7M | 479.8M | 464.1M | 390.8M | -8.0% | 382.6M | — | — | — |
| Equity | 209.2M | 195.9M | 222.5M | 248.9M | 6.0% | — | — | — | — |
| Op CF | 34.6M | 78.0M | 80.6M | 102.4M | 43.5% | 98.0M | — | — | — |
| Inv CF | -6.2M | -9.5M | -15.1M | -37.1M | — | — | — | — | — |
| Fin CF | -56.2M | -45.5M | -73.2M | -100.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MED.DE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MED.DE | MEDICLIN Aktiengesellschaft(you) | $303M | 99 | Strong Buy |
| LIK.DE | LIMES Schlosskliniken AG | $193M | 86 | Strong Buy |
| 1846.HK | EuroEyes International Eye Clinic Limited | $97M | 85 | Strong Buy |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.1B | 87 | Strong Buy |
| FMS | Fresenius Medical Care AG | $12.3B | 94 | Strong Buy |
| M12.DE | M1 Kliniken AG | $414M | 99 | Strong Buy |
| FRE.DE | Fresenius SE & Co. KGaA | $25.5B | 79 | Buy |
| SBS.DE | Stratec SE | $317M | 86 | Strong Buy |
| ILM1.DE | Medios AG | $326M | 73 | Buy |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.8B | 100 | Strong Buy |
Peer medians: ROE 5.7% · P/E 16.6x · Gross margin 45.7%